Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Fees

Cameron E. Williams, a director at Bio-Key International, acquired 1,429 shares of common stock on March 27, 2024, as payment for board meeting attendance fees.

Summary

• On March 27, 2024, Cameron E. Williams, a director of Bio-Key International, acquired 1,429 shares of common stock.
• The shares were issued under the Issuer's Amended and Restated 2015 Equity Incentive Plan.
• The acquisition was in payment of board meeting attendance fees.
• Following the transaction, Williams directly owns 2,053 shares of Bio-Key International.
• The transaction was reported on March 29, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director increasing their stake is a mild positive.

Positives

• A director is increasing their stake in the company, which could be seen as a positive signal.

Industry Context

This type of transaction, where board members receive equity in lieu of cash compensation, is relatively common, especially for smaller companies. It aligns the interests of the board with those of shareholders.

Related Party Transactions

• The issuance of shares to Cameron Williams, a director, in lieu of cash compensation for board service constitutes a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Bio-Key International, Director, Share Acquisition, Form 4, Equity Incentive Plan, Board Fees, BKYI